Melinda Taschetta-Millane, Editorial Director
Melinda Taschetta-Millane, Editorial Director
Blog | Melinda Taschetta-Millane, Editorial Director | Women's Health| October 03, 2017

The Role of Personalized Breast Cancer Screening

The Role of Personalized Breast Cancer Screening

It is once again October, Breast Cancer Awareness Month. The American Cancer Society (ACS) estimates that about 252,710 new cases of invasive breast cancer and 63,410 new cases of carcinoma in situ (CIS) will be diagnosed in 2017. About 40,610 women will die from breast cancer this year.

Only lung cancer beats out breast cancer in women for the leading cause of cancer deaths, and the chance that a woman will die from breast cancer is about 1 in 37, or about 2.7 percent, according to the ACS. Since 2007, breast cancer death rates have been steady in women younger than 50, but have continued to decrease in older women. These decreases are attributed to the result of earlier and better screening procedures and treatments.

Having the topic of breast density in the limelight has also helped to raise awareness, and as of this month, and thanks to many, many hours of dedicated work from industry lobbyists, 30 states now require some level of patient density notification, according to densebreast-info.org.

Monica Saini, M.D., medical director — ABUS at GE Healthcare, says it’s an exciting time to be a breast radiologist “because we no longer have to prescribe to a one-size-fits-all screening exam,” she said in the itnTV video “Innovative Breast Cancer Screening for Women with Dense Breast Tissue.” In it, she discusses the advancements for women in personalized breast care, and how automated breast ultrasound (ABUS) helps meet the challenges of screening and diagnostic imaging of dense breast tissue.

“Instead of prescribing to this system, we can use a multimodality approach to individualize each woman’s breast care,” she explained, stating that the industry now has new tools, like risk assessment, and knows to look at the personal history of each patient, her family history of cancer and her personal biology, which is best demonstrated by breast density. “Using these tools together, we can come up with an individualized plan for each patient. We start with the gold standard of screening mammography.

“Now we have new advancements in technology with tomosynthesis that allows us to reduce the callback rate,” she continued. “But we have even newer technologies like automated breast ultrasound which allow us to screen dense breasted patients, which is about 40 percent of the population. When we use these tools together, we have a synergistic type of effect. So the magic is we find more cancer. And that’s the ultimate goal for a breast radiologist is to increase our cancer detection rate but decrease our false positives. New technology has given us game-changing applications that can be applied to breast imaging.”

You can watch the full video with Saini at http://bit.ly/2jI6KF2. In this issue, ITN is premiering its automated breast ultrasound systems comparison chart. You can review the system specs from participating companies on page 47
of this issue.

Related Content

Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...
Georgia Becomes 38th State With Breast Density Inform Law
News | Breast Density | May 06, 2019
Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective...
American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines
News | Mammography | May 03, 2019
The American Society of Breast Surgeons (ASBrS) has released the first screening mammography guidelines based on a...
Hologic Launches Trident HD Specimen Radiography System
Technology | Breast Biopsy Systems | April 26, 2019
Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Women With Coronary Artery Wall Thickness at Risk for Heart Disease
News | Cardiac Imaging | April 25, 2019
The thickness of the coronary artery wall as measured by magnetic resonance imaging (MRI) is an independent marker for...
The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

The Cianna Medical Savi Scout Radar Localization system, showing the console, detector and the marker, with a size comparison and X-ray images inside breast tissue. For more information on the learning curve of its use http://sabcs16.posterview.com/nosl/p/P1-11-06.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr
Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.
GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...